Generics 15

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Vortioxetine manufacturers

15 products found

Filters

15 products found

vortioxetine

Oral solution 10 mg/5 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q2 2024
Manufacturer #8593
It is a private R&D and business development organization established in the 2000s, specializing in the design and development of new pharmaceutical products worldwide. They have an average of 5-6 new developments per year, an average of 8-10 DCPs per year, more than 60 dossier updates in the last 10 years, they have more than 3 valid and approved patent applications, and approximately 140 MAs worldwide.

Manufacturer usually replies in 2 days

vortioxetine

Tablets, film coated 5 mg , 10 mg , 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Brintellix
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 6 days

vortioxetine

Tablets, film coated 5 mg, 10 mg, 15 mg, 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 7 days

vortioxetine

Tablets, film coated 5 mg, 10 mg, 15 mg, 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 3 days

vortioxetine

Tablets, film coated 5 mg, 10 mg, 15 mg, 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
EU MA's Granted
Manufacturer #21467

Manufacturer usually replies in 9 days

vortioxetine

Tablets, film coated 5 mg, 10 mg, 15 mg, 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Available for
Technology transfer
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

vortioxetine

Tablets, film coated 5 mg, 10 mg, 15 mg, 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

vortioxetine

Tablets, film coated 5 mg, 10 mg, 15 mg, 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
Dossier availability date: Q2 2025
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 23 days

vortioxetine

Tablets 5 mg , 10 mg , 15 mg, 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

vortioxetine

Tablets 20 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
EU GMP
Manufacturer #12677

Manufacturer usually replies in 4 days

vortioxetine

Tablets, film coated 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan
Manufacturer #20797
A state of art GMP manufacturing site for medicinal products, medical devices, herbal products, and solid cosmetics. The company has an active pipeline of niche pharmaceutical products marketed in the MENA region and Europe under the company’s branding. The company also offers pipeline products with a private label under special agreements.

Manufacturer usually replies in 3 days

vortioxetine

Tablets 5 mg, 10 mg, 15 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, EU GMP
Manufacturer #20273

Manufacturer usually replies in 21 days

vortioxetine

Tablets 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, PICS
Manufacturer #21118

Manufacturer usually replies in 12 days

vortioxetine

Tablets, chewable 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Registered in
Pakistan
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #25406

vortioxetine

Tablets 5 mg, 10 mg, 20 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #32970

Vortioxetine:

Vortioxetine, which is also known by its common trade names Trintellix and Brintellix, is a medication used in the treatment of major depressive disorder. It is classified in a group of pharmaceutical products termed as serotonin modulators and stimulators, due to its multimodal mechanism of action towards the serotonin neurotransmitter system. Simultaneously modulating one or multiple serotonin receptors while inhibiting the reuptake of serotonin. Vortioxetine was originally developed by the pharmaceutical drugs manufacturing company Lundbeck in Denmark, who initially published the rationale and synthesis report in a 2011 paper. In 2013 it was approved both by the FDA for marketing in the United States and by the EMA for use in the European Union. Currently, it is produced by vortioxetine manufacturers and vortioxetine suppliers and sold to distributors under various brand names for sale and wholesale on the global marketplace, where it can be found at varying price points.

Method of action of vortioxetine:

Vortioxetine acts to treat major depression syndrome by increasing the concentration of serotonin in the brain through the inhibition of serotonin reuptake in the synapse and by modulating certain serotonin receptors. This modulating action consists of activating certain receptors while also blocking or antagonizing others, categorizing vortioxetine as an atypical class of antidepressants known as serotonin modulators and stimulators.

Form and dosage of vortioxetine:

The ultimate packaging is dependent on both the manufacturers and suppliers and thus it can come in multiple forms. However, common types on the for sale list of distributors consist of forms such as tablets, film-coated, and oral solutions. Vortioxetine is a prescription-only medication, as such, it can only be taken under the advice of a healthcare professional. Where it is recommended that adults initially take 10 mg once a day by mouth, being adjusted to a maximum of 20 mg based on patient response. Dosages for the elderly are similarly adjusted, with caution being advised from manufacturers for administration by mouth over a maximum daily 10 mg amount.

vortioxetine on Pipelinepharma:

Currently, at the time of wiring, a search on the online B2B Pipelinepharma marketplace reveals 4 trusted vortioxetine manufacturers and vortioxetine suppliers from our global list of sellers. These manufacturers, suppliers, and distributors have vortioxetine available for wholesale order and are located in the European Union. These companies have been verified by the Pipelinepharma team according to strict quality control, ensuring no dead ends and a hassle-free sourcing experience.

Price of vortioxetine and how to buy:

As with the purchase of all drugs, the cost of vortioxetine varies significantly based on numerous factors, as such, it is highly specific to the buyers’ circumstance and needs. Although the historic cost of purchase for vortioxetine remains confidential between both B2B parties in the online Pipelinepharma marketplace, manufacturers or distributors may choose to list the desired price on their listing to facilitate a trade. This provides a reference on which to begin negotiations or simply expedites the transaction by offering a rapid buying option. If a price has been indicated, an ‘Accept’ and ‘Negotiate’ button will be displayed. If no cost has been set, then a ‘Get offer’ button will be shown instead.